United States· US:50991-999_472e3862-eab9-2279-e063-6394a90adb4c
Norgesic Forte
A medicinal product containing orphenadrine citrate; aspirin; caffeine, registered in United States by Poly Pharmaceuticals, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE
- Manufacturer
- Poly Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11509919996060 TABLET, MULTILAYER in 1 BOTTLE (50991-999-60)
- ndc1150991-999-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5235394f-8d34-4c6d-a7df-d647dad967e5 GET /v1/drugs/5235394f-8d34-4c6d-a7df-d647dad967e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50; 770; 60",
"substance": "ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE",
"productndc": "50991-999",
"dosage_form": "TABLET, MULTILAYER",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1; mg/1",
"application_number": "ANDA075141",
"marketing_category": "ANDA"
}See everything about orphenadrine citrate; aspirin; caffeine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.